Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 2.601% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) CCCNC(=O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1
b.) Cc1ccc(Cl)cc1NC(=S)N1CCC(c2ccccc2)C1
c.) O=C(Cn1c(C(=O)O)cc2ccccc21)c1ccccc1
d.) COc1ccc(-n2nnnc2SCc2nc(N)nc(N3CCOCC3)n2)cc1
Answer: d. COc1ccc(-n2nnnc2SCc2nc(N)nc(N3CCOCC3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-n2nnnc2SCc2nc(N)nc(N3CCOCC3)n2)cc1
COc1ccc(-n2nnnc2SCc2nc(N)nc(N3CCOCC3)n2)cc1
4-[[1-(4-methoxyphenyl)tetrazol-5-yl]sulfanylmethyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine